Advanced formulations use ionic liquid-based microemulsions that improve local delivery by approximately three-fold while retaining biological function
To elucidate which proteins are susceptible to carbonylation in -cells in T1D settings, we recently mapped over 1000 individual carbonylated proteins in islets from pre-diabetic NOD mice side by side with MIN6 -cells treated with 4-HNE or cytokines ( Table 1 ), including, Sec61 translocon subunit alpha 1 (SEC61A1), ADP ribosylation factor 1 and 3 (ARF1, 3), RAB3 GTPase activating protein catalytic subunit 1 (RAB3GAP1), N ethylmaleimide sensitive factor (NSF), RAB18, member RAS oncogene family (RAB18), Syntaxin binding protein 1 (MUNC18-1), RAB7A, member RAS oncogene family (RAB7A), Syntaxin 5 (STX5), Adaptor related protein complex 2 subunit alpha 2 (AP2A2), Endoplasmic reticulum Golgi intermediate compartment 1 (ERGIC1), Dynamin 1 like (DNM1L), Transmembrane p24 trafficking protein 10 (TMED10), Post GPI attachment to proteins 1 (PGAP1) and JNK interacting protein 4 (JIP4) (182), we observed insulin (INS2) carbonylation upon exposure to 4-HNE (183)
Moreover, neither the total amount of supplied calories nor the concentration of blood glucose correlated with systemic levels of BHB (Extended Data Fig
Bacterial reads were then assembled into contigs using megahit (v1.2.9) (Li et al., 2015) and then reads were mapped against the contigs, with a minimum percentage of identity of 95% and a minimum coverage of 80%
He B, Yang X, Li Y, Huang D, Xu X, Yang W, Dai Y, Zhang H, Chen Z, Cheng W (2018a) TLR9 (toll-like receptor 9) agonist suppresses angiogenesis by differentially regulating VEGFA (vascular endothelial growth factor a) and sFLT1 (soluble vascular endothelial growth factor receptor 1) in preeclampsia
